Bio

Michael Anderson is a Partner at Mainsail Partners. He has spent twenty years as an investor in private companies. Michael currently serves on the board of Apptega, Boostlingo and Syncro. He formerly served on the board of Inspect Point, PeraHealth (acquired), Bio-Optronics (acquired by Advarra) and FairWarning (acquired by Imprivata). Prior to joining Mainsail, Michael was a Principal at Summit Partners, a private equity and venture firm. Prior to Summit, Michael worked for Danaher Corporation, Onex Corporation, Nassau Capital and Gleacher Partners. Michael’s prior Board experience includes CareCentrix, Medspring Urgent Care (acquired by Fresenius Medical Care), National Veterinary Associates (acquired by Ares Management) and Integrated DNA Technologies (acquired by Danaher Corporation). Michael received an A.B. in Economics, Magna Cum Laude, from Princeton University, where he was a member of the rowing team, and an M.B.A. from the Stanford University Graduate School of Business.